Analysen zu Santander S.A. (Banco Santander Central Hispano)
| 04.12.25 | Santander Buy | Goldman Sachs Group Inc. | |
| 27.11.25 | Santander Buy | UBS AG | |
| 17.11.25 | Santander Buy | Deutsche Bank AG | |
| 31.10.25 | Santander Overweight | Barclays Capital | |
| 31.10.25 | Santander Buy | Goldman Sachs Group Inc. | |
| 30.10.25 | Santander Buy | UBS AG | |
| 30.10.25 | Santander Buy | Deutsche Bank AG | |
| 29.10.25 | Santander Buy | Jefferies & Company Inc. | |
| 29.10.25 | Santander Buy | UBS AG | |
| 13.10.25 | Santander Buy | UBS AG | |
| 29.09.25 | Santander Buy | UBS AG | |
| 25.09.25 | Santander Buy | Goldman Sachs Group Inc. | |
| 27.08.25 | Santander Buy | Goldman Sachs Group Inc. | |
| 08.08.25 | Santander Buy | Deutsche Bank AG | |
| 04.08.25 | Santander Buy | UBS AG | |
| 30.07.25 | Santander Kaufen | DZ BANK | |
| 30.07.25 | Santander Buy | UBS AG | |
| 14.07.25 | Santander Buy | UBS AG | |
| 02.07.25 | Santander Buy | Jefferies & Company Inc. | |
| 01.07.25 | Santander Buy | UBS AG | |
| 26.06.25 | Santander Buy | UBS AG | |
| 20.06.25 | Santander Buy | UBS AG | |
| 16.05.25 | Santander Buy | Deutsche Bank AG | |
| 14.05.25 | Santander Buy | Goldman Sachs Group Inc. | |
| 05.05.25 | Santander Buy | UBS AG | |
| 05.05.25 | Santander Buy | Jefferies & Company Inc. | |
| 02.05.25 | Santander Kaufen | DZ BANK | |
| 01.05.25 | Santander Buy | UBS AG | |
| 30.04.25 | Santander Buy | UBS AG | |
| 28.04.25 | Santander Buy | UBS AG | |
| 16.04.25 | Santander Buy | UBS AG | |
| 14.04.25 | Santander Overweight | Barclays Capital | |
| 09.04.25 | Santander Buy | Jefferies & Company Inc. | |
| 31.03.25 | Santander Buy | UBS AG | |
| 27.03.25 | Santander Buy | Goldman Sachs Group Inc. | |
| 24.03.25 | Santander Buy | UBS AG | |
| 06.03.25 | Santander Buy | Deutsche Bank AG | |
| 25.02.25 | Santander Buy | Jefferies & Company Inc. | |
| 13.02.25 | Santander Buy | Goldman Sachs Group Inc. | |
| 11.02.25 | Santander Kaufen | DZ BANK | |
| 06.02.25 | Santander Buy | Deutsche Bank AG | |
| 06.02.25 | Santander Buy | UBS AG | |
| 05.02.25 | Santander Buy | Goldman Sachs Group Inc. | |
| 05.02.25 | Santander Buy | UBS AG | |
| 21.01.25 | Santander Buy | UBS AG | |
| 16.01.25 | Santander Buy | Jefferies & Company Inc. | |
| 20.12.24 | Santander Buy | Goldman Sachs Group Inc. | |
| 13.12.24 | Santander Overweight | Barclays Capital | |
| 05.12.24 | Santander Buy | Deutsche Bank AG | |
| 05.12.24 | Santander Buy | UBS AG |
Aktuelle Aktienanalysen
| 12.12.25 | Fraport Hold | Jefferies & Company Inc. | |
| 12.12.25 | thyssenkrupp Halten | DZ BANK | |
| 12.12.25 | Schneider Electric Equal Weight | Barclays Capital | |
| 12.12.25 | Linde Buy | Jefferies & Company Inc. | |
| 12.12.25 | BNP Paribas Equal Weight | Barclays Capital | |
| 12.12.25 | Meta Platforms Overweight | JP Morgan Chase & Co. | |
| 12.12.25 | Amazon Overweight | JP Morgan Chase & Co. | |
| 12.12.25 | Alphabet A Overweight | JP Morgan Chase & Co. | |
| 12.12.25 | Oracle Kaufen | DZ BANK | |
| 12.12.25 | Beiersdorf Kaufen | DZ BANK | |
| 12.12.25 | Nike Buy | Jefferies & Company Inc. | |
| 12.12.25 | Linde Buy | Deutsche Bank AG | |
| 12.12.25 | Roche Hold | Deutsche Bank AG | |
| 12.12.25 | HUGO BOSS Hold | Deutsche Bank AG | |
| 12.12.25 | Carl Zeiss Meditec Hold | Deutsche Bank AG | |
| 12.12.25 | Schneider Electric Buy | Deutsche Bank AG | |
| 12.12.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 12.12.25 | Givaudan Buy | Deutsche Bank AG | |
| 12.12.25 | SAF-HOLLAND Kaufen | DZ BANK | |
| 12.12.25 | Diageo Overweight | Barclays Capital | |
| 12.12.25 | TotalEnergies Overweight | Barclays Capital | |
| 12.12.25 | Shell Overweight | Barclays Capital | |
| 12.12.25 | Eni Overweight | Barclays Capital | |
| 12.12.25 | BP Overweight | Barclays Capital | |
| 12.12.25 | STMicroelectronics Underweight | Barclays Capital | |
| 12.12.25 | Rio Tinto Neutral | UBS AG | |
| 12.12.25 | Aurubis Neutral | UBS AG | |
| 12.12.25 | LVMH Moet Hennessy Louis Vuitton Buy | UBS AG | |
| 12.12.25 | Ferrari Buy | UBS AG | |
| 12.12.25 | TAG Immobilien Buy | Warburg Research | |
| 12.12.25 | SCHOTT Pharma Buy | UBS AG | |
| 12.12.25 | Hennes & Mauritz AB Underperform | Bernstein Research | |
| 12.12.25 | Schneider Electric Buy | UBS AG | |
| 12.12.25 | Inditex Outperform | Bernstein Research | |
| 12.12.25 | PUMA Outperform | Bernstein Research | |
| 12.12.25 | Novo Nordisk Neutral | UBS AG | |
| 12.12.25 | Zalando Underperform | Bernstein Research | |
| 12.12.25 | Carl Zeiss Meditec Neutral | UBS AG | |
| 12.12.25 | SCHOTT Pharma Buy | UBS AG | |
| 12.12.25 | UBM Development buy | Erste Group Bank | |
| 12.12.25 | Linde Buy | UBS AG | |
| 12.12.25 | Saint-Gobain Buy | Jefferies & Company Inc. | |
| 12.12.25 | Brenntag Hold | Deutsche Bank AG | |
| 12.12.25 | Givaudan Neutral | UBS AG | |
| 12.12.25 | L'Oréal Neutral | UBS AG | |
| 12.12.25 | TUI Buy | Deutsche Bank AG | |
| 12.12.25 | TotalEnergies Neutral | Goldman Sachs Group Inc. | |
| 12.12.25 | Shell Buy | Goldman Sachs Group Inc. | |
| 12.12.25 | Eni Buy | Goldman Sachs Group Inc. | |
| 12.12.25 | BP Buy | Goldman Sachs Group Inc. |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.